Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Once a Day Immunosuppression Regimen: Outcomes and Compliance

Trial Profile

Once a Day Immunosuppression Regimen: Outcomes and Compliance

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 09 Oct 2018

At a glance

  • Drugs Azathioprine (Primary) ; Tacrolimus (Primary) ; Mycophenolic acid
  • Indications Renal transplant rejection
  • Focus Adverse reactions
  • Most Recent Events

    • 01 Oct 2018 Planned End Date changed from 1 Jun 2020 to 1 Jun 2021.
    • 01 Oct 2018 Planned primary completion date changed from 1 Dec 2019 to 1 Dec 2020.
    • 01 Oct 2018 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top